Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Jan 2006):

Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.

Full Abstract

Application of clopidogrel before percutaneous coronary intervention in patients with acute coronary syndrome reduces the risk of cardiac events. Clopidogrel administration before surgery increases bleeding complications after CABG. Therefore,the antithrombotic effect of the low-dose combination of clopidogrel and aspirin was investigated in an in vivo pig model of coronary artery thrombus formation with cyclic flow reductions. The platelet inhibitory effect was determined by platelet aggregation and CFR, according to the methodology described by Folts. CFR were initiated by endothelial damage and placement of a constrictor around the LAD. 30 min after CFR were established, clopidogrel (0. I mg/kg or 5 mg/kg), aspirin (I mg/kg or 7 mg/kg) or LDC (0. I mg/kg clopidogrel and I mg/kg aspirin) were administered orally. CFR-frequency was determined for further 240 min.CFR-frequency (CFR/30 min) was significantly reduced at 60 min in response to aspirin (7 mg/kg, -48%, p<0.05), and at 120 min in response to clopidogrel (5 mg/kg,-65%, p<0.05) but not at low doses of either compound. In contrast, LDC of clopidogrel (0. I mg/kg) plus aspirin (I mg/kg) resulted in a complete and rapid abrogation of CFR at 90 min (-70%, p<0.05 y. Furthermore, LDC led to reduction of platelet aggregation when CFR-frequency was already significantly decreased. In contrast, high dose groups presented a significant reduction of platelet aggregation prior to CFR-frequency decrease. Low dose combination of clopidogrel plus aspirin demonstrates a potent over additive anti-thrombotic effect in vivo with a significant reduction in thrombus formation early after drug application. The effect occurs before inhibition of platelet aggregation is detectable.

 

Author information

Author/s: Bierbach, Benjamin (B); Horstick, Georg (G); Berg, Oliver (O); Heimann, Axel (A); Münzel, Thomas (T); Vahl, Christian-Friedrich (CF); Kempski, Oliver (O); Darius, Harald (H);

Affiliation: Department of Cardiothoracic and Vascular Surgery, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany. bier.bach(-atsign-)gmx.de

Journal and publication information

Publication Type: Journal Article

Journal: Thrombosis and haemostasis (Thromb Haemost), published in Germany. (Language: eng)

Reference: 2006-Feb; vol 95 (issue 2) : pp 354-61

Dates: Created 2006/02/27; Completed 2006/05/26; Revised 2009/11/03;

PMID: 16502561, status: MEDLINE (last retrieval date: 11/3/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Platelet Aggregation Inhibitors (0) ; Aspirin (50-78-2) ; Ticlopidine (55142-85-3) ; clopidogrel (90055-48-4)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

2/27/1991
12/30/2007
Higher Relevance Score (44)
Lower Relevance Score (33)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index